Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience

BACKGROUND: Treatment with radium-223 has been shown to increase survival and to delay skeletal events related to bone metastases of patients with metastatic Castration Resistant Prostate Cancer (mCRPC). This treatment has also proved to be well tolerated, and hematological toxicity, in particular a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate Int
Main Authors: Costa, Renato P., Bordonaro, Sebastiano, Cappuccio, Francesco, Tripoli, Vincenzo, Murabito, Alessandra, Licari, Maria, Valerio, Maria R., Tralongo, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: Asian Pacific Prostate Society 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424691/
https://ncbi.nlm.nih.gov/pubmed/30937295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2018.08.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados